According to our (Global Info Research) latest study, the global Cosmetic Grade Nicotinamide Mononucleotide market size was valued at US$ 12.22 million in 2025 and is forecast to a readjusted size of US$ 31.82 million by 2032 with a CAGR of 14.8% during review period.
Cosmetic grade nicotinamide mononucleotide (NMN) is a niche but fast-growing part of both the NMN and cosmetic ingredients markets. In simple terms, NMN is a derivative of vitamin B3 and a direct precursor to NAD⁺, a molecule that cells use for energy, DNA repair, and many basic functions. When we talk about “cosmetic grade” NMN, we mean NMN that is produced and tested specifically for use on the skin, not for eating. Suppliers label it as “cosmetic grade, not food grade”, and sell it as a high-purity (usually ≥99%) active ingredient for use in creams, serums, masks and other skincare products.
From a market definition point of view, cosmetic grade NMN sits in the overlap of three areas: advanced cosmetic actives, NAD⁺-boosting “longevity” ingredients, and next-generation vitamin B3-type products. Many websites that sell cosmetic raw materials describe NMN as an “anti-aging superhero” ingredient that offers similar benefits to niacinamide (another B3 form) but with a stronger effect, such as helping moisturize the skin, strengthen the barrier, reduce wrinkles, brighten tone and improve hyperpigmentation. These claims are based on NMN’s biological role as a NAD⁺ precursor and on early research showing positive effects on skin cells and animal models, which has encouraged formulators to position NMN as a premium, science-based cosmetic active.
In 2024, global Cosmetic Grade Nicotinamide Mononucleotide production reached approximately 4.3 MT, with an average global market price of around US$ 2,479 per kg. The global single-line production capacity ranges from 0.5 to 1 MT per year. The industry's gross profit margin is approximately 30%-50%.
Market trends for cosmetic grade NMN are closely tied to the larger “longevity” and “science-based skincare” movements. Over the last few years, NAD⁺, NMN and related molecules have become popular in the wellness and longevity community, with large investments and heated scientific debates about how well these strategies actually work in humans. At the same time, beauty brands have been racing to add more “clinical” and “lab-tested” stories to their products. NAD⁺ skincare, which focuses on ingredients that maintain or raise NAD⁺ levels in skin cells, has begun to appear in fashion and lifestyle media as a new type of anti-aging approach. Cosmetic grade NMN fits directly into this trend, allowing brands to market themselves as sitting at the intersection of dermatology, anti-aging research and premium cosmetics.
Another strong driver is the need for differentiation in a very crowded anti-aging skincare market. Niacinamide, retinoids, vitamin C and peptides are now widely used and understood by consumers, which makes it harder for brands to stand out by using these ingredients alone. NMN, as a “next-generation B3” and NAD⁺ precursor, offers a fresh story. Suppliers highlight that NMN can offer all the typical niacinamide benefits (improving moisture, barrier function, tone and fine lines) with a “higher intensity” and extra support for cellular energy and repair. Because it is still relatively new, NMN gives brands the chance to launch hero products with unique messaging, higher price points, and a sense of cutting-edge innovation.
The rise of premium and dermocosmetic segments is also shaping this market. Many new NMN skincare launches position themselves as “clinical-grade,” “doctor-backed,” or “med-spa” style products, often combining NMN with other powerful actives such as peptides, hyaluronic acid, growth factors and retinoids. Cosmetic grade NMN is attractive in this context because it comes with high purity, clear documentation, and a technical data package that fits the expectations of dermatologists, aestheticians and advanced skincare consumers. Dermatology-style brands are also interested in NMN’s reported anti-inflammatory and barrier-supporting actions, which may be useful for sensitive, damaged or post-procedure skin.
This report is a detailed and comprehensive analysis for global Cosmetic Grade Nicotinamide Mononucleotide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cosmetic Grade Nicotinamide Mononucleotide market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Cosmetic Grade Nicotinamide Mononucleotide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Cosmetic Grade Nicotinamide Mononucleotide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Cosmetic Grade Nicotinamide Mononucleotide market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cosmetic Grade Nicotinamide Mononucleotide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cosmetic Grade Nicotinamide Mononucleotide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, EffePharm, Mirailab Bioscience, Bontac-bio, ABA Chemical, CELFULL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cosmetic Grade Nicotinamide Mononucleotide market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Concentration≥98%
Concentration<98%
Market segment by Production Method
Enzymatic Synthesis
Chemical Synthesis
Market segment by Sales Channel
Direct-to-consumer Online
Offline Retail
Professional Channel
Market segment by Application
Skin Care Products
Facial Care Products
Hair Care Products
Major players covered
GeneHarbor
Herbalmax
Genex Formulas
EffePharm
Mirailab Bioscience
Bontac-bio
ABA Chemical
CELFULL
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cosmetic Grade Nicotinamide Mononucleotide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cosmetic Grade Nicotinamide Mononucleotide, with price, sales quantity, revenue, and global market share of Cosmetic Grade Nicotinamide Mononucleotide from 2021 to 2026.
Chapter 3, the Cosmetic Grade Nicotinamide Mononucleotide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cosmetic Grade Nicotinamide Mononucleotide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cosmetic Grade Nicotinamide Mononucleotide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cosmetic Grade Nicotinamide Mononucleotide.
Chapter 14 and 15, to describe Cosmetic Grade Nicotinamide Mononucleotide sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Cosmetic Grade Nicotinamide Mononucleotide. Industry analysis & Market Report on Cosmetic Grade Nicotinamide Mononucleotide is a syndicated market report, published as Global Cosmetic Grade Nicotinamide Mononucleotide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cosmetic Grade Nicotinamide Mononucleotide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.